Main Session
Sep
27
PQA 01 - PQA 01: Gastrointestinal Cancer and Central Nervous System
2288 - Efficacy and Prognosis of Neoadjuvant Chemoimmunotherapy Followed by Concurrent Chemoradiotherapy in Unresectable Esophageal Cancer: The First Single-Center Real-World Study
Presenter(s)
Xiaofei Zhang, MD - Shanghai cancer hospital, Shanghai, shanghai